Back to 
Wasatch Advisors LP
Wasatch Advisors LP
CYTK
Showing 0 of 17 quarters
Position history for Wasatch Advisors LP's holdings in Cytokinetics, Incorporated
No. Wasatch Advisors exited its CYTK (Cytokinetics) position in Q1 2023. Its Q4 2022 13F listed 368,183 shares worth $16.9M. Wasatch Advisors already held CYTK in its Q1 2019 13F, the earliest on record, and held it in 16 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.